BACKGROUND: The estimated prevalence of lower urinary tract symptoms (LUTS) related
to benign prostatic hyperplasia (BPH) in men> 50 yr of age is around 30%, similar in all …

Purpose The purpose of the study is to estimate the trends in drug prescriptions and the
hospitalization rates for lower urinary tract symptoms/benign prostatic hyperplasia …

Background Male lower urinary tract symptoms (LUTS) are one of the most treated diseases,
but little is known about patient trajectories in current clinical practice. Objective To describe …

OBJECTIVE To describe the profile and management of patients medically treated for
benign prostatic hyperplasia (BPH) in primary care in four European countries, as the …

Abstract Context Alpha-blockers (ABs) and 5-alpha reductase inhibitors have an established
role in treating male lower urinary tract symptoms (LUTS) attributed to benign prostatic …

Objective To examine trends in medical management of men with benign prostatic
hyperplasia/lower urinary tract symptoms (BPH/LUTS) in relation to sentinel events specific …

Objectives: We aimed to describe treatment strategies for lower urinary tract symptoms
suggestive of benign prostatic hyperplasia (LUTS/BPH), adherence to and persistence with …

Methods: Cases were 1933 men with incident prostate cancer. Population controls included
1994 age-matched men. In-person interviews collected sociodemographic characteristics …

The first paper describes the design and baseline characteristics of patients in the BPH
Registry and Patient Survey in the USA. This important study will provide information on …

Comparative Effectiveness and Safety of Monodrug Therapies f... : Medicine Comparative
Effectiveness and Safety of Monodrug Therapies for Lower Urinary Tract Symptoms Associated …